Lapatinib Completed Phase 1 Trials for Advanced or Metastatic ErbB2-overexpressing Breast Cancer / Neoplasms, Breast Other

IndicationsStatusPurposePhase
CompletedOther1
clinicaltrials.gov IdentifierTitleDrugs
NCT00821054A Study to Examine the Effects of Low and High-fat Meals on Orally Administered Lapatinib in Metastatic ErbB2 Positive Breast Cancer Patients